David A. Benaron

The International Society for Optical Engineering operates as society for optics and photonics. It advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. The company was founded on July 1, 1955 and is headquartered in Bellingham, WA.

Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA.

Spectros Corp. develops, markets, and licenses medical devices based on in vivo molecular optical technologies, including clinical devices for detection of ischemia and cancer. Its medical devices utilize optical technologies that speed diagnosis, enable real-time therapies and reduce complications. The company's flagship product, the T-Stat Tissue Oximeter, is a medical device that is sensitive to ischemia, an insufficient supply of oxygen to tissue. The firm is also developing molecular imaging contrast agents for surgical guidance during breast and prostate cancer surgeries. Spectros was incorporated on April 19, 1995 and is headquartered in Portola Valley, CA.